BTG

(redirected from BTG plc)
Also found in: Financial, Wikipedia.

BTG

abbreviation for
British Technology Group
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
References in periodicals archive ?
M2 PRESSWIRE-August 28, 2019-: Varicose Vein Treatment Market Comprehensive Analysis to 2025 by Top Players Alma Lasers Ltd, Angiodynamics, Biolitec AG, BTG PLC, Energist Ltd, Medtronic, Lumenis, Sciton, Syneron, Teleflex
Boston Scientific sold the assets as part of its acquisition of UK-based medical device maker BTG plc. (LSE: BTG), to address antitrust concerns.
(NYSE: BSX) has closed the acquisition of UK-based medical device maker BTG plc. (LSE: BTG), the company said.
Medical company Boston Scientific Corporation (NYSE:BSX) on Monday announced the acquisition of BTG plc (LSE:BTG).
M2 PHARMA-August 19, 2019-Boston Scientific acquires BTG plc
Boston Scientific (BDX) has agreed to divest certain assets to Varian Medical Systems (VAR) to settle Federal Trade Commission charges that Boston Scientific's proposed $4.2B acquisition of medical equipment and pharmaceutical supplier BTG plc would violate federal antitrust law, the FTC announced.
(Alliance News) - FTSE 250-listed healthcare firm BTG PLC said Wednesday that its proposed GBP3.3 billion acquisition by Boston Scientific Corp has received merger control clearance from the US Federal Trade Commission.
Release date- 05082019 - BTG plc (LSE: BTG), the global healthcare company, today announced the start of a randomized double-blinded clinical study, initiated by researchers at the University of Maryland School of Medicine (UMSOM), that examines the role of DigiFab (Digoxin Immune FAB (ovine)) in patients with an elevated risk of acute kidney injury undergoing coronary artery bypass graft (CABG) surgery.
Hoffmann-La Roche Ltd., Novartis AG, Eli Lilly and Company, Bayer AG, Fresenius Kabi AG, BTG plc, Boston Scientific Corporation, and Medtronic.
Chicago: Fitch Ratings has affirmed Boston Scientific Corp.'s (Boston Scientific) ratings, including its Long-Term Issuer Default Rating (IDR) at 'BBB', following the company's announcement that it will acquire BTG plc. The Rating Outlook is Stable.
Boston Scientific Corp (BSC), a US-based medical device maker, has received financing from Barclays Plc (LSE: BARC) to fund the purchase of rival firm, BTG Plc.